A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
about
Physiological and pathological implications of 5-hydroxymethylcytosine in diseasesFunctions of TET Proteins in Hematopoietic TransformationConnections between TET proteins and aberrant DNA modification in cancerThe TET2 interactors and their links to hematological malignanciesClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondIDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaAge-related clonal hematopoiesis associated with adverse outcomesT-cell lymphomas, a challenging disease: types, treatments, and future.Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.Toward a Biology-Driven Treatment Strategy for Peripheral T-cell LymphomaThe genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaGlobal transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.DNMT3A in haematological malignancies.No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.Pathophysiology of T follicular helper cells in humans and miceConcurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.TET proteins and 5-methylcytosine oxidation in hematological cancersDiscordant intracellular and plasma D-2-hydroxyglutarate levels in a patient with IDH2 mutated angioimmunoblastic T-cell lymphomaSTX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomasIdentification of cell-type-specific mutations in nodal T-cell lymphomas.Acute loss of TET function results in aggressive myeloid cancer in mice.Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesDNA methylation and hydroxymethylation in hematologic differentiation and transformation.The Impact of DNA Methylation in Hematopoietic Malignancies.Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.The genetics of nodal marginal zone lymphomaGenetic landscape of T- and NK-cell post-transplant lymphoproliferative disordersThe Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid developmentRecurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.X. Challenges and future directions in peripheral T-cell lymphoma.Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?A three-signal model of T-cell lymphoma pathogenesisMolecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant Transformation.
P2860
Q26749375-6CA38225-8561-468E-A199-1196A49733B7Q26778323-06F1AA0C-0688-4ACB-850F-07FEFC2D78B8Q26865671-F10A3302-D0CC-4DFE-BECB-B66D19BFB422Q27002485-DE07B522-4157-4D83-841E-A7ECD10DDCF2Q27027493-CA77D973-97D5-4BA6-A713-C1A7CB6C758BQ27853198-328EA140-B4EA-42F2-97D7-F15C9F5945B0Q28070073-C82302B9-89AC-4609-B52E-70C409982288Q28386602-C433FCA3-77AB-46E8-92EA-3D153F1AF053Q30244553-B90E3176-ED99-45CC-928B-3381DD70E8CDQ33423854-0AA91DC5-5606-4B6F-8B0B-69FED81AF864Q33566663-E8BA7574-36E4-4E81-9033-5B1DA6E0DF03Q33670421-320436B6-1BD1-4140-8898-6BD1982C6E43Q33796552-E1224F8B-C5D5-43CD-AC4E-B1029D7B3F46Q34444243-387262F9-E012-499B-A958-1831B2DD282BQ34463554-57B578A4-E950-4F5E-90CF-C1FB0BDC4EEFQ35126129-79EAF8D5-F963-4482-9BFD-EC939BEA20C5Q35695090-E7A4698C-A1C1-45D6-BBD0-5D52349034D8Q35832062-C6E8C914-A63A-4DFA-844C-C85618FF8CADQ36197509-52487535-6FB6-405C-B75B-B3A98D039CC1Q36262067-F8B8863B-9FE8-4527-B460-8ADBBE80F857Q36262870-14F0E9F9-6759-45B5-A1C9-6A7DF63D50ABQ36269008-A16E7786-7531-4B27-8BAD-7E826B3648D3Q36360635-BE497944-F5B2-4E5D-986A-DDAEA4F7CB0FQ36372043-4CCCD872-76FC-4078-8AA4-2A6ADA48788CQ36395976-A5ED4AB8-8A95-4C84-9B0C-65B3B070314CQ36724810-3D3887A0-E64B-44F9-851C-B6F4E104D1DEQ37210452-FFB06001-19A5-4CB7-83AA-F98CB9FF496EQ37243257-10C3CAA8-57D8-4DCD-B805-E3DE9EC75C3EQ37437248-F2374C7A-7F2E-45E2-ABA1-E2FB428A000AQ37526352-F82EA0FE-BEAC-4ED0-8A7D-452537379B97Q37549960-42A67AE1-20D5-45E1-AFC8-AA64DC8D91BCQ37609908-6E9EBB01-E5FE-4ADB-B96F-C7E5B5E40698Q38210794-3F9AD7CA-381A-4802-8E21-D3CDCE9A5C53Q38231548-66169455-2823-4A3A-A39E-3C4136DFDD87Q38289038-4615016B-8609-416F-8E93-977D55DEE8ECQ38372504-6B4A89F5-9804-49E9-AFBC-C4A462654758Q38524000-83EBDAF5-678C-4A99-AB34-C1C208A51622Q38542620-E46F89BB-3E8B-42AA-846F-F406AF72CCFDQ38593164-106DD7D6-CE05-46A9-9776-D48CE71280F1Q38629368-17D6D78D-295B-4D75-A705-067FDBC51637
P2860
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@ast
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@en
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@nl
type
label
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@ast
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@en
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@nl
prefLabel
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@ast
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@en
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
@nl
P2093
P2860
P50
P1433
P1476
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
@en
P2093
Abner Louissaint
Andrew A Lane
David Dorfman
David M Weinstock
Diederik van Bodegom
Ephraim Hochberg
Eric Jacobsen
Giorgio Inghirami
Julie Teruya-Feldstein
Kristen Stevenson
P2860
P304
P356
10.1182/BLOOD-2013-10-531509
P407
P577
2013-12-17T00:00:00Z